Skip to main content
UniHealth

Doctor search

Nicole Borau, MD

Endocrinology · Los Gatos

NPI 1285836403

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
2 carriers
Office
1

Offices

1 location · El Camino Health Medical Network LLC · 202 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

14 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Borau’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026

California Medical Board record

Licence A107439 · Current

Licensed to practise in California · since 2009 · expires 2028-08-31 · Albany Medical College of Union University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$59,206

Medicare paid this office $59,206 for 222 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)135$24,658$107
Injection, denosumab, 1 mg11$18,152None
Short return visit (20+ min)63$5,537$79
New patient visit (45+ min)19$2,917$154
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's107$2,316$15
See all 9 services
Every Original Medicare service billed
Return visit (30+ min)135$24,658$107
Injection, denosumab, 1 mg11$18,152None
Short return visit (20+ min)63$5,537$79
New patient visit (45+ min)19$2,917$154
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's107$2,316$15
New patient visit (30+ min)16$1,258$79
Office for the evaluation and management of established patient that may not require presence of healthcare professional11$471$25
Injection of drug or substance under skin or into muscle11$161$11
Hemoglobin a1c level16$152$10

Who their Medicare patients are

222 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 9% · Women 69% · Also on Medicaid 13% · Health risk score 1.23. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 75% · Diabetes 55% · Chronic kidney disease 30% · Coronary heart disease 28% · Cancer 16% · Depression 16% · Atrial fibrillation 14% · Heart failure 12% · COPD 12% · Stroke 8%.

The office billed $237,187, Medicare allowed $81,511 and paid $59,206; for 1,668 services of 15 kinds; $20,260 of it was for drugs given in the office and $38,946 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242221,668741.23$237,187$59,206
20232154,139731.22$283,095$68,822
20222021,330731.19$179,231$44,176
20211761,235731.29$123,052$34,895
2020148460741.33$67,401$22,057
20194246741.21$16,452$3,115
2018124254731.29$85,946$19,345
2017110251731.60$73,069$18,903
2016101238711.56$68,257$17,856
2015109480721.43$86,400$24,170
201487253711.47$62,542$17,512
20133273701.46$18,309$6,658

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Return visit (30+ min)141$27,349$106
Injection, denosumab, 1 mg11$17,864None
Short return visit (20+ min)65$5,977$75
New patient visit (45+ min)22$3,253$148
New patient visit (30+ min)21$1,799$86
Office for the evaluation and management of established patient that may not require presence of healthcare professional15$860$24
Injection of drug or substance under skin or into muscle13$387$12

2022: 6 services

Original Medicare services billed in 2022
Return visit (30+ min)124$26,130$113
Short return visit (20+ min)58$5,362$79
New patient visit (45+ min)24$3,567$149
Telephone medical discussion with physician, 11-20 minutes27$1,721$57
New patient visit (30+ min)14$1,244$89
Office for the evaluation and management of established patient that may not require presence of healthcare professional27$1,078$22

2021: 7 services

Original Medicare services billed in 2021
Return visit (30+ min)88$15,946$117
Short return visit (20+ min)70$5,853$71
Telephone medical discussion with physician, 11-20 minutes39$4,332$76
Telephone medical discussion with physician, 21-30 minutes19$2,653$115
Office for the evaluation and management of established patient that may not require presence of healthcare professional24$1,187$22
New patient visit (30+ min)12$1,139$95
Telephone medical discussion with physician, 5-10 minutes13$280$22

2020: 6 services

Original Medicare services billed in 2020
Return visit (30+ min)50$6,212$90
Telephone medical discussion with physician, 11-20 minutes60$5,524$69
Telephone medical discussion with physician, 21-30 minutes19$2,101$96
Short return visit (20+ min)33$2,036$57
Telephone medical discussion with physician, 5-10 minutes52$1,982$34
Office for the evaluation and management of established patient that may not require presence of healthcare professional19$873$20

2019: 1 service

Original Medicare services billed in 2019
Return visit (30+ min)28$2,106$75

2018: 4 services

Original Medicare services billed in 2018
Return visit (30+ min)79$12,599$86
Short return visit (20+ min)39$2,411$56
New patient visit (30+ min)13$1,095$84
Office for the evaluation and management of established patient that may not require presence of healthcare professional13$359$17

2017: 4 services

Original Medicare services billed in 2017
Return visit (30+ min)75$11,189$85
New patient visit (45+ min)19$2,579$136
Short return visit (20+ min)27$1,913$58
Office for the evaluation and management of established patient that may not require presence of healthcare professional16$604$18

2016: 5 services

Original Medicare services billed in 2016
Return visit (30+ min)59$8,996$90
Short return visit (20+ min)34$2,662$59
New patient visit (45+ min)17$2,407$142
New patient visit (30+ min)11$954$87
Office for the evaluation and management of established patient that may not require presence of healthcare professional17$509$16

2015: 7 services

Original Medicare services billed in 2015
Return visit (30+ min)66$11,770$97
New patient visit (45+ min)28$4,051$145
Fine needle aspiration using imaging guidance14$2,622$146
Short return visit (20+ min)21$1,604$70
New patient visit (30+ min)12$1,152$96
Ultrasonic guidance for needle placement14$854$61
Office for the evaluation and management of established patient that may not require presence of healthcare professional15$644$20

2014: 5 services

Original Medicare services billed in 2014
Return visit (30+ min)48$7,563$87
New patient visit (45+ min)15$1,893$126
New patient visit (30+ min)19$1,890$99
Short return visit (20+ min)24$1,654$64
Office for the evaluation and management of established patient that may not require presence of healthcare professional31$947$18

2013: 2 services

Original Medicare services billed in 2013
Return visit (30+ min)18$2,684$99
New patient visit (45+ min)17$2,436$143

Drugs they prescribed that Part D paid

$1,204,329

Pharmacies billed $1,204,329 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,556) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

1,370 generic and 1,042 brand-name prescriptions · $1,204,329 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic142$296,721$2,090
Jardiance155$237,314$1,531
Trulicity51$106,743$2,093
Tradjenta35$50,144$1,433
Farxiga30$45,221$1,507
See all 45 drugs
Every Part D drug this clinician prescribed
Ozempic142$296,721$2,090
Jardiance155$237,314$1,531
Trulicity51$106,743$2,093
Tradjenta35$50,144$1,433
Farxiga30$45,221$1,507
Toujeo Max Solostar29$44,752$1,543
Humalog Kwikpen U-20017$43,978$2,587
Mounjaro25$38,968$1,559
Rybelsus15$38,595$2,573
Januvia20$29,815$1,491
Prolia15$24,898$1,660
Toujeo Solostar18$24,059$1,337
Tresiba Flextouch U-20013$12,696$977
Basaglar Kwikpen U-10018$8,704$484
Humalog Kwikpen U-10037$8,540$231
Nano 2nd Gen Pen Needle75$7,857$105
Tresiba Flextouch U-10031$7,701$248
Lantus Solostar63$7,261$115
Novolog Flexpen18$5,515$306
Levothyroxine351$5,292$15
Synthroid54$5,048$93
Metformin207$2,479$12
Humalog11$1,929$175
Tirosint11$1,778$162
Atorvastatin94$1,480$16
Ezetimibe43$1,392$32
Ultra-Fine Short Pen Needle17$1,325$78
Metformin Hcl Er70$1,209$17
Pravastatin59$1,110$19
Rosuvastatin52$1,068$21
Repaglinide35$1,006$29
Ultra-Fine Mini Pen Needle11$905$82
Glipizide70$746$11
Methimazole68$677$10
Hydrocortisone11$625$57
Alendronate58$559$10
Lisinopril55$521$9
Losartan56$499$9
Liothyronine13$451$35
Glipizide Er21$435$21
Glimepiride37$355$10
Simvastatin22$331$15
Cabergoline14$268$19
Amlodipine Besylate23$238$10
Pioglitazone11$200$18

Year by year

Part D prescribing by year
20242,5563770% (0)41%$1,204,329
20232,7853700% (0)43%$1,549,542
20222,3723170% (0)42%$1,121,178
20212,0342570% (0)48%$1,002,449
20201,6592340% (0)46%$644,917
20191,1181900% (0)45%$350,342
20181,001131None35%$217,615
20171,0051240% (0)37%$183,025
20168631120% (0)34%$135,215
2015604910% (0)40%$114,247
2014369590% (0)42%$63,371
2013104230% (0)32%$19,082

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 49 drugs

Part D drugs prescribed in 2023
Jardiance165$276,916$1,678
Ozempic131$261,695$1,998
Trulicity80$183,185$2,290
Farxiga44$60,618$1,378
Tradjenta37$60,400$1,632
Lantus Solostar96$58,556$610
Toujeo Max Solostar45$48,837$1,085
Rybelsus16$48,690$3,043
Humalog Kwikpen U-20015$43,811$2,921
Novolog Flexpen29$35,656$1,230
Humulin 70/30 Kwikpen15$33,499$2,233
Humalog Kwikpen U-10026$32,412$1,247
Toujeo Solostar18$31,037$1,724
Prolia18$30,011$1,667
Januvia13$21,106$1,624
Mounjaro14$20,166$1,440
Tresiba Flextouch U-20015$18,808$1,254
Tresiba Flextouch U-10023$11,847$515
Vascepa21$9,903$472
Basaglar Kwikpen U-10018$8,582$477
Nano 2nd Gen Pen Needle80$8,173$102
Synthroid78$7,992$102
Levothyroxine389$6,769$17
Icosapent Ethyl17$6,676$393
Levemir Flexpen11$5,535$503
Humulin 70-3012$4,565$380
Insulin Lispro Kwikpen U-10016$3,803$238
Ultra-Fine Mini Pen Needle23$2,667$116
Repaglinide26$2,471$95
Atorvastatin121$2,170$18
Metformin170$1,919$11
Ultra-Fine Short Pen Needle12$1,904$159
Ezetimibe33$1,875$57
Metformin Hcl Er77$1,733$23
Rosuvastatin67$1,329$20
Glipizide87$1,278$15
Methimazole81$1,182$15
Pravastatin64$1,005$16
Ultra-Fine Nano Pen Needle14$906$65
Losartan52$795$15
Glimepiride36$690$19
Simvastatin35$599$17
Amlodipine Besylate33$546$17
Alendronate33$500$15
Pioglitazone11$458$42
Glipizide Er22$451$21
Lisinopril59$369$6
Irbesartan11$328$30
Fenofibrate20$295$15

2022: 43 drugs

Part D drugs prescribed in 2022
Trulicity97$169,151$1,744
Jardiance102$164,424$1,612
Ozempic49$95,595$1,951
Farxiga72$81,081$1,126
Rybelsus24$61,250$2,552
Lantus Solostar81$46,187$570
Tradjenta28$42,983$1,535
Toujeo Max Solostar36$42,776$1,188
Humalog Kwikpen U-20012$35,711$2,976
Toujeo Solostar17$34,162$2,010
Humalog Kwikpen U-10019$23,966$1,261
Novolog Flexpen28$22,863$817
Lantus12$21,291$1,774
Prolia14$21,216$1,515
Januvia14$17,915$1,280
Vascepa33$17,384$527
Basaglar Kwikpen U-10021$9,206$438
Humulin N Kwikpen13$7,598$584
Levothyroxine333$7,381$22
Tresiba Flextouch U-10013$7,308$562
Nano 2nd Gen Pen Needle75$6,953$93
Synthroid60$6,211$104
Insulin Lispro Kwikpen U-10023$4,271$186
Ultra-Fine Short Pen Needle12$2,489$207
Atorvastatin129$2,371$18
Ultra-Fine Mini Pen Needle18$1,892$105
Repaglinide26$1,880$72
Metformin144$1,675$12
Fenofibrate30$1,400$47
Ezetimibe15$1,330$89
Metformin Hcl Er49$1,195$24
Pravastatin68$1,119$16
Rosuvastatin45$1,023$23
Glimepiride30$822$27
Methimazole63$704$11
Glipizide52$696$13
Losartan47$679$14
Ultra-Fine Nano Pen Needle13$616$47
Alendronate45$521$12
Glipizide Er20$481$24
Simvastatin33$434$13
Lisinopril53$426$8
Amlodipine Besylate23$369$16

2021: 40 drugs

Part D drugs prescribed in 2021
Trulicity110$154,415$1,404
Jardiance91$134,013$1,473
Rybelsus45$69,391$1,542
Lantus Solostar93$54,252$583
Humalog Kwikpen U-20029$47,798$1,648
Toujeo Solostar34$46,007$1,353
Tradjenta29$39,772$1,371
Farxiga36$35,740$993
Lantus22$33,438$1,520
Januvia23$29,116$1,266
Humalog Kwikpen U-10033$28,332$859
Ozempic14$27,294$1,950
Toujeo Max Solostar18$25,960$1,442
Novolog Flexpen19$23,639$1,244
Humalog13$23,456$1,804
Humulin 70/30 Kwikpen15$23,265$1,551
Levemir Flextouch12$21,455$1,788
Vascepa41$19,650$479
Basaglar Kwikpen U-10019$14,342$755
Insulin Lispro15$10,276$685
Levothyroxine297$7,620$26
Nano 2nd Gen Pen Needle71$6,471$91
Synthroid47$5,691$121
Insulin Lispro Kwikpen U-10018$5,537$308
Ultra-Fine Nano Pen Needle23$2,452$107
Ultra-Fine Mini Pen Needle20$1,943$97
Metformin107$1,209$11
Atorvastatin73$1,177$16
Fenofibrate31$1,141$37
Metformin Hcl Er48$805$17
Rosuvastatin34$757$22
Methimazole58$744$13
Glipizide75$710$9
Alendronate48$639$13
Pravastatin27$469$17
Glimepiride17$370$22
Simvastatin23$319$14
Losartan18$317$18
Amlodipine Besylate19$220$12
Lisinopril38$212$6

2020: 36 drugs

Part D drugs prescribed in 2020
Jardiance60$71,349$1,189
Lantus Solostar103$54,050$525
Trulicity31$47,953$1,547
Humalog Kwikpen U-20023$42,867$1,864
Toujeo Solostar32$41,754$1,305
Tradjenta39$39,191$1,005
Januvia24$32,330$1,347
Levemir Flextouch17$28,732$1,690
Lantus18$26,333$1,463
Novolog Flexpen21$20,855$993
Basaglar Kwikpen U-10025$20,498$820
Humalog Kwikpen U-10025$19,505$780
Humalog15$16,340$1,089
Baqsimi25$14,851$594
Insulin Lispro13$7,626$587
Levothyroxine269$7,257$27
Ultra-Fine Nano Pen Needle67$5,819$87
Synthroid50$4,787$96
Insulin Lispro Kwikpen U-10015$4,245$283
Ultra-Fine Mini Pen Needle17$1,588$93
Nano 2nd Gen Pen Needle16$1,414$88
Metformin100$977$10
Atorvastatin44$866$20
Methimazole61$832$14
Glimepiride28$825$29
Glipizide75$798$11
Hydrocortisone12$761$63
Alendronate43$564$13
Metformin Hcl Er31$509$16
Fenofibrate12$431$36
Pravastatin23$403$18
Gabapentin11$237$22
Losartan17$178$10
Amlodipine Besylate16$138$9
Simvastatin18$123$7
Lisinopril28$121$4

2019: 26 drugs

Part D drugs prescribed in 2019
Jardiance36$37,035$1,029
Toujeo Solostar29$34,158$1,178
Lantus Solostar61$24,099$395
Humalog Kwikpen U-20015$23,149$1,543
Januvia20$22,897$1,145
Humalog Kwikpen U-10024$20,209$842
Tradjenta23$19,899$865
Novolog Flexpen16$16,757$1,047
Levemir Flextouch16$16,746$1,047
Basaglar Kwikpen U-10022$15,533$706
Novolog Mix 70-30 Flexpen12$13,838$1,153
Levothyroxine194$4,780$25
Ultra-Fine Nano Pen Needle52$4,228$81
Synthroid41$2,852$70
Repaglinide18$1,824$101
Ultra-Fine Mini Pen Needle11$1,228$112
Methimazole72$949$13
Alendronate71$832$12
Glimepiride28$823$29
Metformin52$612$12
Atorvastatin23$539$23
Glipizide30$411$14
Losartan18$227$13
Amlodipine Besylate15$172$11
Simvastatin11$172$16
Lisinopril13$107$8

2018: 19 drugs

Part D drugs prescribed in 2018
Lantus Solostar34$35,824$1,054
Toujeo Solostar16$31,328$1,958
Januvia21$17,478$832
Humalog Kwikpen U-10014$12,536$895
Novolog Flexpen12$8,296$691
Levothyroxine233$3,938$17
Repaglinide12$1,836$153
Synthroid41$1,736$42
Ultra-Fine Nano Pen Needle20$1,523$76
Methimazole84$1,007$12
Hydrocortisone13$739$57
Glipizide59$565$10
Alendronate83$554$7
Metformin45$486$11
Glimepiride23$412$18
Atorvastatin15$344$23
Losartan35$206$6
Lisinopril28$146$5
Gemfibrozil13$130$10

2017: 19 drugs

Part D drugs prescribed in 2017
Toujeo Solostar24$31,183$1,299
Lantus Solostar35$23,350$667
Januvia28$16,775$599
Humalog Kwikpen U-10018$16,417$912
Levothyroxine291$4,673$16
Synthroid49$1,784$36
Ultra-Fine Nano Pen Needle19$1,329$70
Hydrocortisone14$633$45
Methimazole65$558$9
Alendronate80$523$7
Glipizide59$417$7
Metformin41$369$9
Glimepiride23$300$13
Losartan22$98$4
Gemfibrozil12$96$8
Hydrochlorothiazide16$75$5
Amlodipine Besylate11$75$7
Lisinopril12$40$3
Metoprolol11$18$2

2016: 18 drugs

Part D drugs prescribed in 2016
Toujeo Solostar18$18,247$1,014
Humalog Kwikpen U-10024$18,198$758
Lantus Solostar27$17,310$641
Januvia16$10,189$637
Tradjenta12$5,064$422
Levothyroxine260$3,782$15
Bd Ultra-Fine Pen Needle23$1,521$66
Alendronate87$837$10
Hydrocortisone16$635$40
Methimazole60$620$10
Synthroid20$571$29
Metformin29$520$18
Glimepiride22$405$18
Atorvastatin11$349$32
Glipizide38$284$7
Hydrochlorothiazide21$100$5
Lisinopril20$43$2
Metoprolol12$19$2

2015: 11 drugs

Part D drugs prescribed in 2015
Lantus Solostar33$30,514$925
Humalog Kwikpen U-10029$21,400$738
Novolog Flexpen16$13,632$852
Levothyroxine183$2,835$15
Bd Ultra-Fine Pen Needle26$1,555$60
Synthroid23$653$28
Methimazole46$525$11
Alendronate39$377$10
Atorvastatin17$286$17
Glipizide29$198$7
Metformin23$182$8

2014: 9 drugs

Part D drugs prescribed in 2014
Lantus Solostar35$21,634$618
Humalog15$9,660$644
Novolog Flexpen11$4,342$395
Bd Ultra-Fine Pen Needle28$1,412$50
Levothyroxine89$1,232$14
Synthroid22$719$33
Methimazole41$673$16
Alendronate18$213$12
Metformin15$163$11

2013: 2 drugs

Part D drugs prescribed in 2013
Levothyroxine33$393$12
Methimazole12$246$21

Money from drug and device companies

$49 in 2025

Industry payments by year
202522None$49
202211None$24

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
MedtronicMinimed 780g$31
1 payment
  • Meals for Minimed 780g · 2025-10-06 · $31
Abbott LaboratoriesFreestyle Libre 3$19
1 payment
  • Meals for Freestyle Libre 3 · 2025-02-07 · $19
See all 2 published payments
Every published payment
MedtronicMeals · 2025-10-06Minimed 780g$31
Abbott LaboratoriesMeals · 2025-02-07Freestyle Libre 3$19
See earlier years (2022)

2022: $24

Payments by company in 2022
Abbott LaboratoriesFreestyle Libre 2$24
1 payment
  • Meals for Freestyle Libre 2 · 2022-03-14 · $24

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
83.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1285836403
Licence
CA A107439California A107439: Current · expires 2028-08-31
Trained
Albany Medical College of Union University, 2005
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RE0101X (207RE0101X)
Mailing address
2585 Samaritan Dr, San Jose, CA, 95124
NPI first listed
2007-06-01
NPI last updated
2020-11-11
NPI record certified
2020-11-11

This is when the NPI record was last certified, not a medical board exam.